為達最佳瀏覽效果,建議使用 Chrome、Firefox 或 Microsoft Edge 的瀏覽器。

請至Edge官網下載 請至FireFox官網下載 請至Google官網下載
晴時多雲

限制級
您即將進入之新聞內容 需滿18歲 方可瀏覽。
根據「電腦網路內容分級處理辦法」修正條文第六條第三款規定,已於網站首頁或各該限制級網頁,依台灣網站分級推廣基金會規定作標示。 台灣網站分級推廣基金會(TICRF)網站:http://www.ticrf.org.tw

《TAIPEI TIMES》 Changhua antibody study highlights success of CECC

From left, Centers for Disease Control Deputy Director-General Chuang Jen-hsiang, National Taiwan University College of Public Health former vice dean Tony Chen, former college dean Chan Chang-chuan, Changhua Public Health Bureau Director Yeh Yen-po and college dean Cheng Shou-hsia attend a news conference in Taipei yesterday.
Photo: CNA

From left, Centers for Disease Control Deputy Director-General Chuang Jen-hsiang, National Taiwan University College of Public Health former vice dean Tony Chen, former college dean Chan Chang-chuan, Changhua Public Health Bureau Director Yeh Yen-po and college dean Cheng Shou-hsia attend a news conference in Taipei yesterday. Photo: CNA

2020/08/28 03:00

By Jake Chung / Staff writer, with CNA

The results of a controversial antibody study in Changhua County, which National Taiwan University (NTU) public health researchers announced yesterday, showed the success of the Central Epidemic Command Center’s (CECC) disease prevention efforts, but not the need for universal screening.

The research was mainly conducted by the county government, while NTU’s College of Public Health assisted with data analysis, former college dean Chan Chang-chuan (詹長權) told a news conference convened in Taipei to announce the preliminary results.

Chan had been calling for mass testing for COVID-19 to identify asymptomatic patients, but the CECC had not taken his advice.

Of the 4,841 high-risk people whose blood samples were analyzed, only four were confirmed positive, a rate of 8.3 positive people per 10,000, Changhua Public Health Bureau Director Yeh Yen-po (葉彥伯) said.

Those who were inspected included confirmed COVID-19 patients and those with high risk of becoming patients, including medical personnel, police officers who helped with disease prevention measures and those under home quarantine after returning from the US, Europe and China, he said.

The study demonstrates that the average citizen does not need an antibody test, Yeh said, adding that the test results prove that Changhua is safe.

Taiwan’s first COVID-19 patient, an unlicensed taxi driver who also became the nation’s first death from the pandemic, was in the county, but the rest of the nation does not need to worry now that Changhua is safe, he added.

Since April, the bureau has bumped heads with the CECC for conducting pathology testing not approved by the center.

An Aug. 15 test that discovered the nation’s 485th case — a Taiwanese teen living in the US who arrived on Aug. 5 for a family visit — was touted as proof that the nation needed to implement general screening for COVID-19, increasing tensions between the CECC and the county government.

At the news conference, Centers for Disease Control Deputy Director-General Chuang Jen-hsiang (莊人祥), the CECC’s spokesman, thanked the research team for announcing the results despite the challenges, saying that the research clarified whether the nation’s disease prevention system has any loopholes.

The results show that the CECC’s policy of using home quarantine and home isolation to prevent transmission of the virus by asymptomatic patients works, Chuang said.

Asked to comment on the results of the mass testing, Premier Su Tseng-chang (蘇貞昌) said it showed that the collaborative efforts of all parts of society to prevent the spread of the disease paid off.

It also showed that mass testing is unnecessary, he added.

Hopefully, people would learn their lesson and follow the CECC’s instructions, he said, adding that in disease prevention, unity is strength.

Regarding controversy surrounding the funding sources and testing agents for the research, Chan said that the school’s study was academic, as its contract with the county government said that it could provide assistance if public health evaluations were needed.

Their study had been approved by NTU’s Institutional Review Board, he added.

NTU provided the funding to purchase the antibody serum solutions and the research team helped analyze the serum samples, Chan said, adding that it did not collect any of the blood samples.

Additional reporting by Sean Lin, Wu Po-hsuan and Lin Hui-chin

新聞來源:TAIPEI TIMES

不用抽 不用搶 現在用APP看新聞 保證天天中獎  點我下載APP  按我看活動辦法

焦點今日熱門
看更多!請加入自由時報粉絲團

網友回應

載入中
此網頁已閒置超過5分鐘,請點擊透明黑底或右下角 X 鈕。